Novavax | NVAX - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
Adma Biologics USD 408.21M 17.88M 2026-06
Agenus USD -199.08M 22.15M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
Cassava Sciences USD 68.14M 6.26M 2026-03
Geron USD 218.61M 10.49M 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
MannKind USD -67.2M 8M 2026-06
Merck USD 41.93B 3.94B 2026-06
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Moderna USD 6.76B 647M 2026-06
Novartis USD 38.93B 7.2B 2026-03
Novavax USD -190.71M 45.94M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06